<SEC-DOCUMENT>0001654954-25-009510.txt : 20250813
<SEC-HEADER>0001654954-25-009510.hdr.sgml : 20250813
<ACCEPTANCE-DATETIME>20250813162106
ACCESSION NUMBER:		0001654954-25-009510
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250813
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250813
DATE AS OF CHANGE:		20250813

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TENAX THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0000034956
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				262593535
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34600
		FILM NUMBER:		251211980

	BUSINESS ADDRESS:	
		STREET 1:		101 GLEN LENNOX DRIVE
		STREET 2:		SUITE 300
		CITY:			CHAPEL HILL
		STATE:			NC
		ZIP:			27517
		BUSINESS PHONE:		919-855-2100

	MAIL ADDRESS:	
		STREET 1:		101 GLEN LENNOX DRIVE
		STREET 2:		SUITE 300
		CITY:			CHAPEL HILL
		STATE:			NC
		ZIP:			27517

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OXYGEN BIOTHERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20080703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SYNTHETIC BLOOD INTERNATIONAL INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SINEQUANON CORP
		DATE OF NAME CHANGE:	19901219
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tennx_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:tennx="http://tennx.com/20250813"><head><title>tennx_8k.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:justify;font:10pt times new roman"><div style="display:none;text-align:justify;font:10pt times new roman;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2025-08-13to2025-08-13" id="ixv-278">0000034956</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2025-08-13to2025-08-13" format="ixt:booleanfalse" id="ixv-279">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="tennx-20250813.xsd"/></ix:references><ix:resources><xbrli:context id="From2025-08-13to2025-08-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000034956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-13</xbrli:startDate><xbrli:endDate>2025-08-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Washington, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:DocumentType" id="ixv-299">8-K</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CURRENT REPORT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen" id="ixv-300">August 13, 2025</ix:nonNumeric></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:EntityRegistrantName" id="ixv-301">Tenax Therapeutics, Inc.</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact name of registrant as specified in its charter)</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="ixv-302">Delaware</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:EntityFileNumber" id="ixv-303">001-34600</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:EntityTaxIdentificationNumber" id="ixv-304">26-2593535</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(State or other jurisdiction of incorporation)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Commission File Number)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(IRS Employer Identification No.)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:EntityAddressAddressLine1" id="ixv-305">101 Glen Lennox Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:EntityAddressAddressLine2" id="ixv-306">Suite 300</ix:nonNumeric></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:EntityAddressCityOrTown" id="ixv-307">Chapel Hill</ix:nonNumeric>, <ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="ixv-308">North Carolina</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:EntityAddressPostalZipCode" id="ixv-309">27517</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Address of principal executive offices) (Zip Code)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:CityAreaCode" id="ixv-310">919</ix:nonNumeric>-<ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:LocalPhoneNumber" id="ixv-311">855-2100</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Registrant&#8217;s telephone number, including area code)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="ixv-312">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="ixv-313">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="ixv-314">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="ixv-315">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-right:#000000 1px solid;border-bottom:#000000 1px solid;text-align:justify;width:100%" cellpadding="2"><tbody><tr style="height:15px"><td style="border-top:#000000 1px solid;border-left:#000000 1px solid;padding:2px;width:33%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Title of each class</p></td><td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:33%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Trading Symbol(s)</p></td><td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:34%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Name of each exchange on which registered</p></td></tr><tr style="height:15px"><td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:Security12bTitle" id="ixv-316">Common Stock, $0.0001 par value per share</ix:nonNumeric></p></td><td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:TradingSymbol" id="ixv-317">TENX</ix:nonNumeric></p></td><td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The <ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-318">Nasdaq</ix:nonNumeric> Stock Market LLC</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Emerging growth company <ix:nonNumeric contextRef="From2025-08-13to2025-08-13" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="ixv-319">&#9744;</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 2.02</strong>&#160;<strong>Results of Operations and Financial Condition.</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">On August 13, 2025, Tenax Therapeutics, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for the second quarter ended June 30, 2025.&#160; A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such a filing.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 9.01</strong> <strong>Financial Statements and Exhibits.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">(d) Exhibits</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Exhibit No.&#160;</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Description&#160;</strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="tennx_ex991.htm">99.1</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="tennx_ex991.htm">Press release dated August 13, 2025.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">104</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cover Page Interactive Data File (embedded within the Inline XBRL document).&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Date: August 13, 2025</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Tenax Therapeutics, Inc.</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="width:50%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:3%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:35%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:12%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">By:</p></td><td style="BORDER-BOTTOM: #000000 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">/s/ Christopher T. Giordano<em> </em></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Christopher T. Giordano</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">President and Chief Executive Officer</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tennx_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html><head><title>tennx_ex991.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 99.1</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="tennx_ex991img3.jpg"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><em>Phase 3 LEVEL Study Ongoing, Enrollment Completion (230 Patients) Expected in First Half of 2026, with Topline Data Expected in Second Half of 2026</em></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><em>On Track to Initiate Second Phase 3 Study, LEVEL-2, in 2025</em></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">CHAPEL HILL, N.C., August 13, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (&#8220;Tenax&#8221; or &#8220;Tenax Therapeutics&#8221; or the &#8220;Company&#8221;), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today reported financial results for the quarter ended June 30, 2025 and provided an update on its recent corporate progress.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#8220;We are pleased with the progress achieved in the second quarter, and remain in a strong position to execute and advance our lead program, TNX-103, in patients with PH-HFpEF,&#8221; said Chris Giordano, President and Chief Executive Officer of Tenax Therapeutics. &#8220;Our sites in North America continue recruiting toward the expanded target of 230 patients, which increased the statistical powering of the LEVEL study.&nbsp; We now anticipate completing enrollment in the first half of 2026. Importantly, we remain on track to initiate our global Phase 3 study, LEVEL-2, this year. Together, both registrational studies are expected to satisfy the requirements, including safety data expectations, to file for approval in the U.S. and other geographies.&#8221;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Recent Corporate and Clinical Highlights</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;text-align:justify;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">Patient enrollment in the Phase 3 LEVEL study of TNX-103 (oral levosimendan) in pulmonary hypertension resulting from heart failure with preserved ejection fraction (PH-HFpEF) continues, with high rates of study and therapy continuation during the blinded and open-label extension stages. Tenax expects to complete enrollment of 230 patients in the first half of 2026. LEVEL is being conducted in Canada and the United States.</td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">A LEVEL protocol design paper, titled &#8220;Oral Levosimendan for the Treatment of Pulmonary Hypertension due to Heart Failure With Preserved Ejection Fraction: Rationale and Design of the LEVEL Trial,&#8221; was published in the <em>Journal of Cardiac Failure</em>.</td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">Tenax remains on track to initiate a second registrational Phase 3 study of TNX-103, LEVEL-2, in patients with PH-HFpEF this year. The protocol for LEVEL-2 has been finalized, and the study will have a global footprint. To date, over 85 sites new to the program, in 15 additional countries, have received qualification visits.</td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">Year to date, Tenax has expanded its operations team, with new heads of Clinical Operations, Data Management, Pharmacovigilance, and Quality Assurance joining the organization to help oversee the execution of the LEVEL program.</td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">In August 2025, the Canadian Intellectual Property Office (CIPO) informed Tenax it has allowed claims within the Company&#8217;s patent application covering the use of TNX-103, TNX-102 (subcutaneous levosimendan), TNX-101 (IV levosimendan), the active metabolites of levosimendan (OR1896 and OR18955) and various combinations of cardiovascular drugs with levosimendan when used to improve exercise performance in PH-HFpEF patients titled: &#8220;LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFpEF).&#8221; Once granted, the patent&#8217;s protections will extend to 2040.</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="tennx_ex991img3.jpg">&nbsp;&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Second Quarter 2025 Financial Results</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Cash position:</strong> Tenax Therapeutics reported cash and cash equivalents of $105.5 million as of June 30, 2025. Tenax expects its cash and cash equivalents to fund the Company through 2027. </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Research and development (R&amp;D): </strong>R&amp;D expenses for the second quarter of 2025 were $6.1 million, compared to $2.3 million for the second quarter of 2024. The increase was primarily attributable to increased clinical development costs associated with our ongoing Phase 3 LEVEL study and our second global Phase 3 study, LEVEL-2, for which we have begun preliminary work, compared with costs for the prior year period, associated with the planning of LEVEL, the initiation of the first LEVEL sites and enrollment of the first LEVEL patients. Additionally, our R&amp;D employee headcount increased during the second quarter of 2025, resulting in an increase in personnel costs as compared to the same quarter in 2024. This increase was comprised of an increase in salary costs as well as an increase in non-cash stock compensation expense. Also, our R&amp;D expenses for the second quarter of 2025 includes $1.0 million of non-cash stock-based compensation expense, representing an increase of $1.0 million as compared to the same period in 2024. This non-cash expense is due to stock options granted in December 2024 that resulted in an associated expense being amortized over a one-year vesting term, in addition to new option grants made in May 2025 that vest and are being expensed over four years.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>General and administrative (G&amp;A): </strong>G&amp;A expenses for the second quarter of 2025 were $5.7 million, compared to $1.3 million for the second quarter of 2024. The increase is primarily due to increased non-cash stock-based compensation expense. Our G&amp;A expenses for the second quarter of 2025 include $3.6 million of non-cash stock-based compensation expense, representing an increase of $3.6 million as compared to the same period in 2024. This is a result of option grants made in December 2024 that resulted in an associated expense being amortized over a one year vesting term, in addition to new option grants made in May 2025 that vest and are being expensed over four years. Additionally, salaries and related performance-based compensation expense, as well as legal and professional fees, increased during the second quarter of 2025 as compared to the same period in 2024. </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Net loss:</strong> Tenax Therapeutics reported a net loss of $10.9 million for the second quarter of 2025, compared to a net loss of $3.6 million for second quarter of 2024. </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="tennx_ex991img3.jpg">&nbsp;&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>About Levosimendan (TNX-101, TNX-102, TNX-103)</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Levosimendan is a novel, first-in-class K-ATP channel activator/calcium sensitizer currently being evaluated to treat pulmonary hypertension (PH) associated with heart failure with preserved ejection fraction (PH-HFpEF). Levosimendan was first developed for intravenous use in hospitalized patients with acutely decompensated heart failure, and it has received market authorization in 60 countries in this indication, although it is not available in the United States or Canada. Tenax&#8217;s Phase 2 HELP study, including its open-label extension stage, demonstrated the potential of IV (TNX-101) and oral (TNX-103) levosimendan to bring durable improvements in exercise capacity and quality of life, as well as other clinical assessments, in patients with PH-HFpEF. TNX-103 (oral levosimendan) is currently being evaluated in LEVEL, a Phase 3, double-blind, randomized, placebo-controlled clinical trial in patients with PH-HFpEF.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>About Tenax Therapeutics</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Tenax Therapeutics, Inc. is a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies. The Company owns global rights to develop and commercialize levosimendan, which it is developing for the treatment of PH-HFpEF, the most prevalent form of pulmonary hypertension globally, for which no product has been approved to date. For more information, visit www.tenaxthera.com. Tenax Therapeutics&#8217; common stock is listed on The Nasdaq Stock Market LLC under the symbol &#8220;TENX&#8221;.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Caution Regarding Forward-Looking Statements</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Except for historical information, all of the statements, expectations and assumptions contained in this press release are forward-looking statements. These forward-looking statements may include information concerning possible or projected future business operations. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: risks of our clinical trials, including, but not limited to, the timing, delays, costs, design, location, initiation, enrollment, and results of such trials; our ability to maintain our culture and recruit, integrate and retain qualified personnel and advisors, including on our Board of Directors; any delays in regulatory review and approval of product candidates in development; risks related to our business strategy, including the prioritization and development of product candidates; intellectual property risks; reliance on third parties, including Orion Corporation, our manufacturers and CROs; risks regarding the formulation, production, marketing, customer acceptance and clinical utility of our product candidates; our estimates regarding the potential market opportunity for our product candidates; the potential advantages of our product candidates; &nbsp;our competitive position; risks associated with our cash needs; volatility and uncertainty in the global economy and financial markets in light of unexpected changes in tariffs and the possibility of pandemics, global financial and geopolitical uncertainties, including in the Middle East and the Russian invasion of and war against the country of Ukraine; changes in legal, regulatory and legislative environments in the markets in which we operate and the impact of these changes on our ability to obtain regulatory approval for our products; and other risks and uncertainties set forth from time to time in our SEC filings. Tenax Therapeutics assumes no obligation and does not intend to update these forward-looking statements except as required by law.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Contact:</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Investor and Media:</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Argot Partners</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">tenax@argotpartners.com </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="tennx_ex991img3.jpg"> </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="MARGIN: 0px;vertical-align:top;" colspan="17"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>Tenax Therapeutics, Inc. </strong></p> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>Consolidated Statements of Operations </strong></p> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>&nbsp; </strong></p></td></tr> <tr style="height:15px"> <td></td> <td style="white-space: nowrap;"></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="6"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>For the three months ended June 30,</strong></p></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="6"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>For the six months ended June 30,</strong></p></td> <td style="white-space: nowrap;"></td></tr> <tr style="height:15px"> <td></td> <td style="white-space: nowrap;"></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>2025</strong></p></td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>2024</strong></p></td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>2025</strong></p></td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>2024</strong></p></td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"></td></tr> <tr style="height:15px"> <td></td> <td style="white-space: nowrap;"></td> <td class="hdcell" colspan="14" style="vertical-align:bottom;text-align:center;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>(in thousands, except for share and per share data)</strong></p></td> <td style="white-space: nowrap;"></td></tr> <tr style="height:15px"> <td></td> <td style="white-space: nowrap;"></td> <td class="ffcell" colspan="2"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" colspan="2"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" colspan="2"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" colspan="2"></td> <td style="white-space: nowrap;"></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Operating expenses</p></td> <td style="white-space: nowrap;"></td> <td class="ffcell" colspan="2"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" colspan="2"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" colspan="2"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" colspan="2"></td> <td style="white-space: nowrap;"></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">Research and development</p></td> <td style="width:1%;white-space: nowrap;"></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:10%;vertical-align:bottom;text-align:right;">6,121</td> <td style="width:1%;white-space: nowrap;"></td> <td style="width:1%;white-space: nowrap;"></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:10%;vertical-align:bottom;text-align:right;">2,327</td> <td style="width:1%;white-space: nowrap;"></td> <td style="width:1%;white-space: nowrap;"></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:10%;vertical-align:bottom;text-align:right;">11,804</td> <td style="width:1%;white-space: nowrap;"></td> <td style="width:1%;white-space: nowrap;"></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:10%;vertical-align:bottom;text-align:right;">5,003</td> <td style="width:1%;white-space: nowrap;"></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">General and administrative</p></td> <td style="white-space: nowrap;"></td> <td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">5,671</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">1,344</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">11,326</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">2,577</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total operating expenses</p></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">11,792</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">3,671</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">23,130</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">7,580</td> <td style="white-space: nowrap;"></td></tr> <tr style="height:15px;background-color:#ffffff"> <td></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell"></td> <td style="white-space: nowrap;"></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Net operating loss</p></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">(11,792</td> <td style="vertical-align:bottom;white-space: nowrap;">)</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">(3,671</td> <td style="vertical-align:bottom;white-space: nowrap;">)</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">(23,130</td> <td style="vertical-align:bottom;white-space: nowrap;">)</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">(7,580</td> <td style="vertical-align:bottom;white-space: nowrap;">)</td></tr> <tr style="height:15px;background-color:#ffffff"> <td></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell"></td> <td style="white-space: nowrap;"></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Interest income</p></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">954</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">104</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">1,884</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">222</td> <td style="white-space: nowrap;"></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Interest expense</p></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">(9</td> <td style="vertical-align:bottom;white-space: nowrap;">)</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">(17</td> <td style="vertical-align:bottom;white-space: nowrap;">)</td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Other income (expense), net</p></td> <td style="white-space: nowrap;"></td> <td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">(9</td> <td style="PADDING-BOTTOM: 1px;vertical-align:bottom;white-space: nowrap;">)</td> <td style="white-space: nowrap;"></td> <td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">1</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">(9</td> <td style="PADDING-BOTTOM: 1px;vertical-align:bottom;white-space: nowrap;">)</td> <td style="white-space: nowrap;"></td> <td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">1</td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss</p></td> <td style="white-space: nowrap;"></td> <td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">(10,847</td> <td style="PADDING-BOTTOM: 3px;vertical-align:bottom;white-space: nowrap;">)</td> <td style="white-space: nowrap;"></td> <td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">(3,575</td> <td style="PADDING-BOTTOM: 3px;vertical-align:bottom;white-space: nowrap;">)</td> <td style="white-space: nowrap;"></td> <td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">(21,255</td> <td style="PADDING-BOTTOM: 3px;vertical-align:bottom;white-space: nowrap;">)</td> <td style="white-space: nowrap;"></td> <td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">(7,374</td> <td style="PADDING-BOTTOM: 3px;vertical-align:bottom;white-space: nowrap;">)</td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss per share, basic and diluted</p></td> <td style="white-space: nowrap;"></td> <td style="vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">(0.27</td> <td style="vertical-align:bottom;white-space: nowrap;">)</td> <td style="white-space: nowrap;"></td> <td style="vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">(1.83</td> <td style="vertical-align:bottom;white-space: nowrap;">)</td> <td style="white-space: nowrap;"></td> <td style="vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">(0.56</td> <td style="vertical-align:bottom;white-space: nowrap;">)</td> <td style="white-space: nowrap;"></td> <td style="vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">(4.65</td> <td style="vertical-align:bottom;white-space: nowrap;">)</td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average number of common shares and prefunded warrants outstanding, basic and diluted</p></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">39,572,177</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">1,958,245</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">38,086,800</td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td style="white-space: nowrap;"></td> <td class="ffcell" style="vertical-align:bottom;text-align:right;">1,586,650</td> <td style="white-space: nowrap;"></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;&nbsp; </p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="tennx_ex991img3.jpg"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;&nbsp; </p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td colspan="9" style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>Tenax Therapeutics, Inc.</strong></p> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>Consolidated Balance Sheets</strong></p> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>&nbsp; </strong></p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>June&nbsp;30, </strong></p> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>2025</strong></p></td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>December&nbsp;31, </strong></p> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>2024</strong></p></td> <td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>ASSETS</strong></p></td> <td style="white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in">(in thousands)</p></td> <td style="white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Current assets</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" colspan="2" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" colspan="2" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">Cash and cash equivalents</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">105,462</td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">94,851</td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">Prepaid expenses and other current assets</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">395</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,835</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total current assets</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">105,857</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">96,686</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Total assets</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">105,857</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">96,686</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><strong>LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</strong></p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Current liabilities</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">Accounts payable</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">562</td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,157</td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">Accrued liabilities</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,965</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,536</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total current liabilities</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,527</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,693</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Total liabilities</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,527</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,693</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Commitments and contingencies</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Stockholders' equity</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Preferred stock, undesignated, authorized 4,818,654 shares</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Series A Preferred stock, par value $0.0001, authorized 5,181,346 shares; issued and outstanding 210, as of June&nbsp;30, 2025 and December&nbsp;31, 2024</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Common stock, par value $0.0001 per share; authorized 400,000,000 shares; issued and outstanding 4,148,495 as of June&nbsp;30, 2025 and 3,420,906 as of December&nbsp;31, 2024, respectively</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Additional paid-in capital</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">439,440</td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">406,848</td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Accumulated deficit </p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(336,110</td> <td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(314,855</td> <td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Total stockholders&#8217; equity </p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">103,330</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">91,993</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total liabilities and stockholders' equity</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">105,857</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td> <td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">96,686</td> <td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px">5</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>tennx-20250813.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 08/13/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:us-types="http://fasb.org/us-types/2025" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:cyd="http://xbrl.sec.gov/cyd-af-sub/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:tennx="http://tennx.com/20250813" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://tennx.com/20250813">
 <annotation>
  <appinfo>
   <link:roleType roleURI="http://tennx.com/role/Cover" id="Cover">
    <link:definition>000001 - Document - Cover</link:definition>
    <link:usedOn>link:presentationLink</link:usedOn>
    <link:usedOn>link:calculationLink</link:usedOn>
    <link:usedOn>link:definitionLink</link:usedOn>
   </link:roleType>
   <link:linkbaseRef xlink:type="simple" xlink:href="tennx-20250813_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="tennx-20250813_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="tennx-20250813_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="tennx-20250813_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
  </appinfo>
 </annotation>
 <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
 <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
 <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
 <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
 <import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
 <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
 <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
 <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
 <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
 <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
 <import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>tennx-20250813_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 08/13/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address Address Line 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre Commencement Issuer Tender Offer</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>tennx-20250813_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 08/13/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://tennx.com/role/Cover" xlink:href="tennx-20250813.xsd#Cover" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://tennx.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>tennx-20250813_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 08/13/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://tennx.com/role/Cover" xlink:href="tennx-20250813.xsd#Cover" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tennx.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>tennx-20250813_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 08/13/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://tennx.com/role/Cover" xlink:href="tennx-20250813.xsd#Cover" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tennx.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tennx_ex991img3.jpg
<TEXT>
begin 644 tennx_ex991img3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  N '@# 2(  A$! Q$!_\0
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$-K'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 13, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Tenax Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000034956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 13,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2593535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">101 Glen Lennox Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Chapel Hill<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">27517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">855-2100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TENX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tennx_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tennx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>tennx-20250813.xsd</File>
    <File>tennx-20250813_cal.xml</File>
    <File>tennx-20250813_def.xml</File>
    <File>tennx-20250813_lab.xml</File>
    <File>tennx-20250813_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tennx_8k.htm">tennx_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tennx_8k.htm": {
   "nsprefix": "tennx",
   "nsuri": "http://tennx.com/20250813",
   "dts": {
    "schema": {
     "local": [
      "tennx-20250813.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "tennx-20250813_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "tennx-20250813_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "tennx-20250813_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tennx-20250813_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tennx_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://tennx.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2025-08-13to2025-08-13",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tennx_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-08-13to2025-08-13",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tennx_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://tennx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001654954-25-009510-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001654954-25-009510-xbrl.zip
M4$L#!!0    ( **"#5O(RQZN2 0  ,P3   2    =&5N;G@M,C R-3 X,3,N
M>'-DS5C+;N,V%-T7Z#^PVK0%*LFRD2 V[ SRF $"9%+ F1;9%31%V41E4B4I
M/_Z^E]3#DBUY)">+R4KT/>>^>4EF^FFWCM&&2L4$GSF!-W 0Y42$C"]G3JI<
MK AC#E(:\Q#'@M.9LZ?*^73[\T_37USW[7[^C!X%2=>4:_0@*=8T1%NF5\B(
MOF*EJ73='/UW9F>"AM[(&]R4O]]C!2S!+0>$02EY!'U(1(@8S98ZN/&#D3\<
M#*]*T*N(]!9+BK D*Z8IT:G$,0JI8DN.P'&4!31!=[\2]+C"<HT32=>8FZ#0
MW49[I:X'D>PE6ZXT^HW\CHP9].2^?/Z&[E/%.%4*O8HX-:ZH/] 3)QZZBV,T
M-PR%YE11N:%AKDZ1%1A!D&&N)KMXYJRT3B:^O]UNO=U"QIZ02XAD,/+?GAG_
MU\F1DD:MT&L?I 60I%)"L?8EVB(5)=Y2;/Q":G-54*"B2XP3%VM=LB*L%E9_
M+O1!*-DBU5#GG,;XABK=;">3@95@Y X"=Q04)$Z7IAM:8QG[4L34SV$5#_4^
MH:K1/2NI!E13OAT5J@/_[>OSJTV_4^8?4MP$#\;CL6^E!?0$62^6$2^@8TO-
M(&5G\(R;W4-J^/ HF3GXRL^$-2AKA%YG4%8V@TBYEFV]D GKK:#EF=* M  J
MJ=M*4HIJFD,MCP@U_2#VC=APANY@5&F9D++F $!0,\'3]7>4 X)*1DJ"X!TX
M@KM'/(BP,>RF7=6^HZI@2L+F&$%0 Y)]"Q $+HY<E2YJ^"AJP8.@!M24\UT)
MM2N/B+7%#&Z"D8/*"?!%R/4CC7 :0QI2_E^*8Q8QLUMI3,W,KP$J8HWEDNH7
MO*8JP82>LP:C$DTQYT+;$6^6L$X2QB-A%VAJMMS$3(MO4"9D/OZ:/S7HM /E
M0<!YYB &V<@^,R6YEI!&C#-K:&#^ N0>#C 76<;4/X96-:1P6/W);^TW'",*
MB-9Q,\-S9@YI8Q$<DS3N23IXT\+)?RK25$U=,;+F-$)VU$U,O\\<Q=9); :3
M_6UE3QZ;3;>HSC\0H0=M4V",]C.SSA;@."FYY4(%G-(G6DYF,2@1"96:P6PY
M#%S_@X**\:)O4$"A\8\9#;13WVB..O#'BPFZO6],]0WRT2%-_<I(@D5M7DTA
M("$UXB?S[MQU(+L?/@MB]9RAF)5;\%SSDQL,X=CT=BK,_>OCP2&T?AX4O+X>
M--]P.MHN",;H57=SS3>?)IOJ'*58V,:\P'K]#M[-?)53KBYTX'!OZF2[@)N/
M[A8[7*:Z%+O*?,F(INACTVG!]7L\N<R+#W#!7J7ST0.W0J)=NDMB>'=J(?=?
M8-W-IUC*FI;/!R7O=Z_^".OJ3I7U83[T2$?!Z&N[]>ER=G^<W/Q]&FMUT/'>
MO5)]";4Y\CVF7:M^23AZ4G?+0?51D^6A4-,]#0U/J4L+T-]F_57VCJ#MOU(N
M&\R'QUZGP5S S<>1Q:F?:;C]'U!+ P04    " "B@@U;,!K&QMH!  ". P
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MR-]CDD!$P@\V1W^&S+0_CX)YL_>UH:3F.TEDV'JU>3E VW9ND:=SO:0%BGA
MAHNX!S8C1/$8?4=3ZPSCKE62;(HRZC]ZS*:)S7CHGOF$HXWNG&T7SU!+ P04
M    " "B@@U;2M;>.!L&  "C.0  %@   '1E;FYX+3(P,C4P.#$S7VQA8BYX
M;6S-6]MNXS80?2_0?YBZ#VV!RHH=M-@821:.DUT8=2Z(O>VB1;&0)=HF*I$&
M2<?VWY?4+99$RDFP2^DEEL5SAF<X1Z.+E?/WNRB$)\0XIN2BT^N>=  1GP:8
M+"\Z&^YXW,>X UQX)/!"2M!%9X]XY_WE]]^=_^ XGZ\>)W!-_4V$B( 10YY
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M\M/CV)C562%62G)?*/5UP1\0PS2X(=DL7RG1<MB7BO^JTT^%Q\2;EKS*MYS
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M\QBE&RQ4P;?/2":)1^V4$.M==;AC(K?4OPVFNW#RKW27_P-02P,$%     @
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M V:.NYXE,) #'(TV ,) #E QWU]X(/U4=(*)AK&.[7*AV1@SZC8;BBN/-37
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M4$L! A0#%     @ HH(-6S :QL;: 0  C@,  !8              ( !> 0
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M%   =&5N;GA?.&LN:'1M4$L! A0#%     @ HH(-6TDO=36+&0  2P$!  \
M             ( !82,  '1E;FYX7V5X.3DQ+FAT;5!+!08     !P ' ,<!
(   9/0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>tennx_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tennx-20250813.xsd" xlink:type="simple"/>
    <context id="From2025-08-13to2025-08-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000034956</identifier>
        </entity>
        <period>
            <startDate>2025-08-13</startDate>
            <endDate>2025-08-13</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2025-08-13to2025-08-13" id="ixv-278">0000034956</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2025-08-13to2025-08-13" id="ixv-279">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2025-08-13to2025-08-13" id="ixv-299">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2025-08-13to2025-08-13" id="ixv-300">2025-08-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2025-08-13to2025-08-13" id="ixv-301">Tenax Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-08-13to2025-08-13" id="ixv-302">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2025-08-13to2025-08-13" id="ixv-303">001-34600</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-08-13to2025-08-13" id="ixv-304">26-2593535</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-08-13to2025-08-13" id="ixv-305">101 Glen Lennox Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-08-13to2025-08-13" id="ixv-306">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-08-13to2025-08-13" id="ixv-307">Chapel Hill</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-08-13to2025-08-13" id="ixv-308">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-08-13to2025-08-13" id="ixv-309">27517</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-08-13to2025-08-13" id="ixv-310">919</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-08-13to2025-08-13" id="ixv-311">855-2100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2025-08-13to2025-08-13" id="ixv-312">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2025-08-13to2025-08-13" id="ixv-313">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2025-08-13to2025-08-13" id="ixv-314">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2025-08-13to2025-08-13" id="ixv-315">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2025-08-13to2025-08-13" id="ixv-316">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2025-08-13to2025-08-13" id="ixv-317">TENX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2025-08-13to2025-08-13" id="ixv-318">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-08-13to2025-08-13" id="ixv-319">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
